[HTML][HTML] Effect of telmisartan and enalapril on ventricular remodeling and kidney prognosis of patients with coronary artery disease complicated with diabetic …

Y Hou, F Zhang, Z Liu, S Su… - Experimental and …, 2017 - spandidos-publications.com
The aim of the present study was to compare the value of telmisartan and enalapril on
ventricular remodeling and kidney prognosis of patients with coronary artery disease …

Effects of telmisartan on vascular endothelial function, inflammation and insulin resistance in patients with coronary heart disease and diabetes mellitus

T Chen, J Xing, Y Liu - Experimental and Therapeutic …, 2018 - spandidos-publications.com
The aim of the present study was to investigate the effects of telmisartan on vascular
endothelial functions, inflammatory factors and insulin resistance of coronary heart disease …

Effects of telmisartan on hypertensive patients with dyslipidemia and insulin resistance

D Xu, J Liu, C Ji, L Zhou, H Guo - Journal of Geriatric Cardiology, 2007 - jgc301.com
Objective To investigate the effects of telmisartan on the blood glucose, blood lipid, blood
insulin, and insulin resistance in the hypertensive patients with dyslipidemia, and also its …

A comparative study of efficacy of enalapril versus telmisartan in patients with diabetic nephropathy

KS Arpitha, K Lakshminarayana - National Journal of …, 2020 - search.proquest.com
In the treatment of both micro-and macroalbuminuria in diabetic patients, either angiotensin-
converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are currently …

Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients

Y Kanno, K Kaneko, M Kaneko, S Kotaki… - Journal of …, 2004 - journals.lww.com
Background Left ventricular hypertrophy (LVH) is frequently found at the initiation of dialysis
therapy for diabetic and hypertensive patients, and is highly predictive of future cardiac …

Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats

W Wienen, S Richard, P Champeroux… - Journal of the Renin …, 2001 - journals.sagepub.com
This study compared the cardiovascular and renal effects of long-term telmisartan (3 and 10
mg/kg/day) and lisinopril (10 mg/kg/day) in an animal model combining hypertension and …

Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan

JP Li, XL He, Q Li - Zhongguo Zhong xi yi jie he za zhi Zhongguo …, 2006 - europepmc.org
Objective To study the effects and the possible mechanism of Tangshenling (TSL) combined
with telmisartan on early diabetic nephropathy (DN). Methods Eighty-one patients with early …

Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats

RP Rao, AK Jain, BP Srinivasan - Journal of the Renin …, 2011 - journals.sagepub.com
Objective: To investigate the combination of telmisartan with trandolapril therapy versus
monotherapy of trandolapril and telmisartan on diabetic nephropathy in type 2 diabetes …

Effect of telmisartan and indapamide on the lipid and glucose metabolism in high-normal blood pressure patients

S Zhao, X Liu, L Liu, W Yu… - International …, 2011 - internationaljournalofcardiology.com
Objective: To investigate the effect of telmisartan and indapamide on lipid and glucose
metabolism in high-normal blood pressure patients. Methods: Ninty-nine high-normal blood …

The telmisartan renoprotective study from incipient nephropathy to overt nephropathy–rationale, study design, treatment plan and baseline characteristics of the …

H Makino, M Haneda, T Babazono… - Journal of …, 2005 - journals.sagepub.com
We planned the INNOVATION study to determine whether telmisartan, an angiotensin-2-
receptor blocker, delays the progression of renal disease from incipient nephropathy to overt …